Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeaki Nishii is active.

Publication


Featured researches published by Shigeaki Nishii.


PLOS ONE | 2010

Enhanced Beetle Luciferase for High-Resolution Bioluminescence Imaging

Yoshihiro Nakajima; Tomomi Yamazaki; Shigeaki Nishii; Takako Noguchi; Hideto Hoshino; Kazuki Niwa; Vadim R. Viviani; Yoshihiro Ohmiya

We developed an enhanced green-emitting luciferase (ELuc) to be used as a bioluminescence imaging (BLI) probe. ELuc exhibits a light signal in mammalian cells that is over 10-fold stronger than that of the firefly luciferase (FLuc), which is the most widely used luciferase reporter gene. We showed that ELuc produces a strong light signal in primary cells and tissues and that it enables the visualization of gene expression with high temporal resolution at the single-cell level. Moreover, we successfully imaged the nucleocytoplasmic shuttling of importin α by fusing ELuc at the intracellular level. These results demonstrate that the use of ELuc allows a BLI spatiotemporal resolution far greater than that provided by FLuc.


Toxicology and Applied Pharmacology | 2011

Nickel differentially regulates NFAT and NF-κB activation in T cell signaling.

Rumiko Saito; Satoshi Hirakawa; Hiroshi Ohara; Makoto Yasuda; Tomomi Yamazaki; Shigeaki Nishii; Setsuya Aiba

Nickel is a potent hapten that induces contact hypersensitivity in human skin. While nickel induces the maturation of dendritic cells via NF-κB and p38 MAPK activation, it also exerts immunosuppressive effects on T cells through an unknown mechanism. To elucidate the molecular mechanisms of its effects on T cells, we examined the effects of NiCl(2) on mRNA expression in human CD3+ T cells stimulated with CD3 and CD28 antibodies. Using a DNA microarray and Gene Ontology, we identified 70 up-regulated (including IL-1β, IL-6 and IL-8) and 61 down-regulated (including IL-2, IL-4, IL-10 and IFN-γ) immune responsive genes in NiCl(2)-treated T cells. The DNA microarray results were verified using real-time PCR and a Bio-Plex(TM) suspension protein array. Suppression of IL-2 and IFN-γ gene transcription by NiCl(2) was also confirmed using Jurkat T cells transfected with IL-2 or IFN-γ luciferase reporter genes. To explore the NiCl(2)-regulated signaling pathway, we examined the binding activity of nuclear proteins to NFAT, AP-1, and NF-κB consensus sequences. NiCl(2) significantly and dose-dependently suppressed NFAT- and AP-1-binding activity, but augmented NF-κB-binding activity. Moreover, NiCl(2) decreased nuclear NFAT expression in stimulated T cells. Using Jurkat T cells stimulated with PMA/ionomycin, we demonstrated that NiCl(2) significantly suppressed stimulation-evoked cytosolic Ca(2+) increases, suggesting that NiCl(2) regulates NFAT signals by acting as a blocker of Ca(2+) release-activated Ca(2+) (CRAC) channels. These data showed that NiCl(2) decreases NFAT and increases NF-κB signaling in T cells. These results shed light on the effects of nickel on the molecular regulation of T cell signaling.


Journal of Biotechnology | 2015

Highly sensitive luciferase reporter assay using a potent destabilization sequence of calpain 3

Mayu Yasunaga; Kazutoshi Murotomi; Hiroko Abe; Tomomi Yamazaki; Shigeaki Nishii; Tetsuya Ohbayashi; Mitsuo Oshimura; Takako Noguchi; Kazuki Niwa; Yoshihiro Ohmiya; Yoshihiro Nakajima

Reporter assays that use luciferases are widely employed for monitoring cellular events associated with gene expression in vitro and in vivo. To improve the response of the luciferase reporter to acute changes of gene expression, a destabilization sequence is frequently used to reduce the stability of luciferase protein in the cells, which results in an increase of sensitivity of the luciferase reporter assay. In this study, we identified a potent destabilization sequence (referred to as the C9 fragment) consisting of 42 amino acid residues from human calpain 3 (CAPN3). Whereas the half-life of Emerald Luc (ELuc) from the Brazilian click beetle Pyrearinus termitilluminans was reduced by fusing PEST (t1/2=9.8 to 2.8h), the half-life of C9-fused ELuc was significantly shorter (t1/2=1.0h) than that of PEST-fused ELuc when measurements were conducted at 37°C. In addition, firefly luciferase (luc2) was also markedly destabilized by the C9 fragment compared with the humanized PEST sequence. These results indicate that the C9 fragment from CAPN3 is a much more potent destabilization sequence than the PEST sequence. Furthermore, real-time bioluminescence recording of the activation kinetics of nuclear factor-κB after transient treatment with tumor necrosis factor α revealed that the response of C9-fused ELuc is significantly greater than that of PEST-fused ELuc, demonstrating that the use of the C9 fragment realizes a luciferase reporter assay that has faster response speed compared with that provided by the PEST sequence.


Cytotechnology | 2017

Identification of regulatory motifs in the CHO genome for stable monoclonal antibody production.

Yasuhiro Takagi; Tomomi Yamazaki; Kenji Masuda; Shigeaki Nishii; Bunsei Kawakami; Takeshi Omasa

Abstract Chinese hamster ovary (CHO) cell lines are widely used for therapeutic protein production. When a transgene is integrated into the genome of a CHO cell, the expression level is highly dependent on the site of integration because of positional effects such as gene silencing. To overcome negative positional effects and establish stable CHO cell lines with high productivity, several regulatory DNA elements are used in vector construction. Previously, we established the CHO DR1000L-4N cell line, a stable and high copy number Dhfr gene-amplified cell line. It was hypothesized that the chromosomal location of the exogenous gene-amplified region in the CHO DR1000L-4N genome contains regulatory motifs for stable protein production. Therefore, we isolated DNA regulatory motifs from the CHO DR1000L-4N cell line and determined whether these motifs act as an insulator. Our results suggest that stable expression of a transgene can be promoted by the CHO genome sequence, and it would be a powerful tool for therapeutic protein manufacturing.


Journal of Pharmaceutical and Biomedical Analysis | 2005

P450 aromatase inhibition assay using a competitive ELISA.

Kazuhiro Matsui; Shigeaki Nishii; Masanori Oka


Archive | 2003

Standard compound for immunoassay for dioxin and method of immunoassay for dioxin

Shigeaki Nishii; Kazuhiro Matsui; Takuya Ishibashi; Masanori Oka; Hiroki Fujihira; Hirotsugu Mishima; Shizuo Kataoka


Archive | 2000

Method for assaying receptor binding property and reagent for the assay

Yoshihiro Soya; Shigeaki Nishii; Kazuhiro Matsui; Takuya Ishibashi; Yoshihisa Kawamura


Bunseki Kagaku | 2000

Down-Sizing in Analytical Chemistry. Determination of bisphenol A by ELISA using an organic solvent-resistant anti-bisphenol A monoclonal antibody.

Shigeaki Nishii; Yoshihiro Soya; Kazuhiro Matsui; Takuya Ishibashi; Yoshihisa Kawamura


Archive | 2009

Element capable of stabilizing gene expression

Tomomi Yamazaki; 友実 山▲崎▼; Kenji Masuda; 兼治 増田; Shigeaki Nishii; 重明 西井; Bunsei Kawakami; 川上 文清; Takeshi Omasa; 健史 大政


Archive | 2010

Expression vector for establishing hyper-producing cells, and hyper-producing cells

Tomomi Yamazaki; Kenji Masuda; Shigeaki Nishii; Bunsei Kawakami

Collaboration


Dive into the Shigeaki Nishii's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoshihiro Nakajima

National Institute of Advanced Industrial Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Kazuki Niwa

National Institute of Advanced Industrial Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge